Evidence map›Paper›PMID 29725420›Full record

ArticleOncology letters2018

Downregulation of TACC3 inhibits tumor growth and migration in osteosarcoma cells through regulation of the NF-κB signaling pathway.

Congran Zhao, Xiaofeng He, Heng Li, Jihui Zhou, Xiuying Han, Dongjun Wang, Guofeng Tian, Fuge Sui

Open access · diamondAbstract read
In one paragraph

Article in Oncology letters, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Congran ZhaoDepartment of Orthopedics, Daqing Longnan Hospital, Daqing, Heilongjiang 163453, P.R. China.
Xiaofeng HeDepartment of Orthopedics, Daqing Longnan Hospital, Daqing, Heilongjiang 163453, P.R. China.
Heng LiDepartment of Orthopedics, Daqing Longnan Hospital, Daqing, Heilongjiang 163453, P.R. China.
Jihui ZhouDepartment of Orthopedics, Daqing Longnan Hospital, Daqing, Heilongjiang 163453, P.R. China.
Xiuying HanDepartment of Orthopedics, Daqing Longnan Hospital, Daqing, Heilongjiang 163453, P.R. China.
Dongjun WangDepartment of Orthopedics, Daqing Longnan Hospital, Daqing, Heilongjiang 163453, P.R. China.
Guofeng TianDepartment of Orthopedics, Daqing Longnan Hospital, Daqing, Heilongjiang 163453, P.R. China.
Fuge SuiDepartment of Orthopedics, Daqing Longnan Hospital, Daqing, Heilongjiang 163453, P.R. China.
Daqing City People's Hospital · CNHarbin Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

TACC3, a member of the transforming acidic coiled-coil protein (TACC) family, is a multifunctional protein that is involved in various biological functions, including proliferation and differentiation of tumor cells, cancer progression and metastasis. The aims of the present study were to examine whether TACC3 expression is associated with the proliferation and migration of osteosarcoma (OS) cells and to investigate the potential underlying molecular mechanisms of TACC3 in OS. First, the levels of mRNA and protein expression in OS cell lines by reverse transcription-quantitative polymerase chain reaction and western blotting, respectively were examined. Second, the effects of TACC3 knockdown and overexpression on the proliferative, migratory and invasive capacities of OS cells were investigated. Finally, western blot analysis was employed to detect the potential mechanism of TACC3 in osteosarcoma. TACC3 expression was significantly increased in osteosarcoma tissues and cell lines, compared to matched controls. The knockdown of TACC3 was able to significantly inhibit the proliferation, migration and invasion of osteosarcoma cells, whereas the overexpression of TACC3 was able to promote cell proliferation and migration. Mechanistically, TACC3 may promote the migration and invasion of osteosarcoma cells via through nuclear factor-κB signaling. These data suggest that TACC3 has an important part in the progression of osteosarcoma and may serve as a potential target for gene therapy.

Indexed as

migrationosteosarcomaproliferationtransforming acidic coiled-coil protein

Identifiers

PMID29725420
PMCPMC5920203
OpenAlexW2794142845

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.